Published 1988
| Version v1.0.0
Journal Article
Open
Drugs in Treatment of Developmental Dyslexia
Creators
Abstract
An acute 2 day trial of methylphenidate (10 mg) and of meclizine (12.5 mg) and a 6 month crossover placebo-controlled chronic trial of meclizine (12.5 mg) in children with developmental dyslexia are reported from the University of Calgary, Alberta, Canada.Files
PNB-2-96.pdf
Files
(1.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:bf10f245a03dc07726c6a028f3da9319
|
1.4 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-2-96
Dates
- Created
-
1988When the item was originally created.